Treatment | NDFsa | WSa | NDFs / WSb |
---|
MK2.III (5μM) | p > 0.37 | p < 0.05 | p < 0.029 |
SB203580 (2.5μM) | p < 0.05 | p < 0.036 | p < 0.014 |
- a Probability that inhibitor treatment results in no significant extension of replicative capacity for NDFs or WS fibroblasts compared to DMSO-treated cells (paired t-test).
- b Probability that the extension of replicative capacity seen for WS cells is not greater than that seen for NDFs for same treatment (unpaired 2-tailed t-test).